1.
Respiration
; 89(1): 62-5, 2015.
Article
in English
| MEDLINE
| ID: mdl-25531296
ABSTRACT
Diffuse alveolar hemorrhage (DAH) is a rare but devastating complication of systemic lupus erythematosus (SLE) with a high early mortality rate. DAH seldom occurs without active organ involvement. Recently, rituximab (RTX), a B cell-targeted therapy, has been reported to be effective for life-threatening autoimmune diseases. We describe a SLE patient who presented with acute respiratory failure due to DAH without other active organ involvement. This condition was dramatically improved with RTX without cyclophosphamide.
Subject(s)
Hemorrhage/drug therapy , Immunologic Factors/therapeutic use , Lung Diseases/drug therapy , Lupus Erythematosus, Systemic/drug therapy , Rituximab/therapeutic use , Adult , Female , Hemorrhage/etiology , Humans , Lung Diseases/etiology , Lupus Erythematosus, Systemic/complications
2.
Gastrointest Endosc
; 65(2): 325-6; discussion 326, 2007 Feb.
Article
in English
| MEDLINE
| ID: mdl-17258996